The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Safety Profile of Oxaliplatin (Single Agent or with 5-FU) from the Large North American Compassionate Use Experience in Advanced Colorectal Cancer (ACC).
 
Hiroko Hasegawa
No Relationships to Disclose
 
Seiichiro Mitani
Honoraria - Merck Serono
 
Takeru Wakatsuki
No Relationships to Disclose
 
Hiroki Hara
Honoraria - Chugai Pharma; Lilly; Merck Serono; Taiho Pharmaceutical; Yakult Honsha
Consulting or Advisory Role - Chugai Pharma; Merck Serono; Ono Pharmaceutical
Research Funding - AstraZeneca (Inst); Boehringer Ingelheim (Inst); Chugai Pharma (Inst); Daiichi Sankyo (Inst); Dainippon Sumitomo Pharma (Inst); Lilly (Inst); Merck Serono (Inst); MSD (Inst); Ono Pharmaceutical (Inst); Taiho Pharmaceutical (Inst); Takeda (Inst)
 
Motohiro Hirao
No Relationships to Disclose
 
Daisuke Takahari
No Relationships to Disclose
 
Keisho Chin
No Relationships to Disclose
 
Shigenori Kadowaki
Research Funding - Boehringer Ingelheim; Bristol-Myers Squibb; Lilly Japan; Ono Pharmaceutical; Taiho Pharmaceutical
 
Kei Muro
Honoraria - Chugai Pharma; Lilly; Merck Serono; Taiho Pharmaceutical; Takeda; Yakult Honsha